Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88GU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,084
Award facts
- Contract value 100% obligated
- $23,084.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,084.34 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injections (2 mL). This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by December 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, representing critical pharmaceutical support for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. As a child contract under this major IDC, this award demonstrates the company's ongoing role as a critical pharmaceutical vendor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded federal pharmaceutical contracts reflects its established capability to meet rigorous federal procurement standards across a diverse portfolio of medical products and therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F88GU?
SPE2DR26F88GU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F88GU worth?
The government has obligated $23,084 on SPE2DR26F88GU.
Is contract SPE2DR26F88GU an order under another contract?
Yes. SPE2DR26F88GU is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88GU competed?
The extent of competition for SPE2DR26F88GU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award